Table 2.
Total (N = 41) | |
---|---|
Any TEAE | 35 (85) |
Serious TEAE | 3 (7) |
TEAE leading to withdrawal | 4 (10) |
TEAEs with overall incidence ≥5% | |
Headache | 11 (27) |
Nausea | 8 (20) |
Dysmenorrheaa | 4 (19) |
Vomiting | 6 (15) |
Toothache | 3 (7) |
Upper respiratory tract infection | 3 (7) |
Weight increase | 3 (7) |
Values are number of patients (percentage).
Sex-specific event; data represent percentage of female patients.
TEAE, treatment-emergent adverse event.